Simulations Plus' (NASDAQ:SLP) Returns On Capital Not Reflecting Well On The Business [Yahoo! Finance]
InnoGI Technologies and Simulations Plus Combine Forces to Offer Next-Level Modeling Solutions for the Prediction of Oral Drug Performance [Yahoo! Finance]
Simulations Plus (SLP) DILIsym Software Licenses Renewed by FDA [Yahoo! Finance]
Earnings Update: Simulations Plus, Inc. Beat Earnings And Now Analysts Have New Forecasts For This Year [Yahoo! Finance]
Simulations Plus stock jumps 25% amid FDA renewal, earnings report [Seeking Alpha]